Pre- and Post- NACT ovarian cancer

NIAID Data Ecosystem2026-05-10 收录

卵巢癌疗效评估

新辅助化疗

数据链接：

https://www.omicsdi.org/dataset/pride/PXD070494 数据链接链接失效反馈

官方服务：

资源简介：

Samples from 22 ovarian cancer patients before and again after neoadjuvant chemotherapy

创建时间：

2025-11-10

Effect analysis of neoadjuvant chemotherapy and combined immunotherapy in the treatment of muscular invasive bladder cancer

膀胱癌

新辅助化疗

Data of MIBC patients admitted to the First Affiliated Hospital of Soochow University from January 2020 to December 2023.These patients received neoadjuvant chemotherapy and underwent radical cystecto

DataCite Commons2024-08-04 更新90

Stable or at least once HER2-low status during neoadjuvant chemotherapy confers survival benefit in patients with breast cancer

乳腺癌

新辅助化疗

Temporal heterogeneity in human epidermal growth factor receptor 2 (HER2) status may be associated with the prognosis of breast cancer. We aimed to clarify the relationship of HER2-low transition duri

DataCite Commons2024-12-03 更新60

Gene mutation variation after neo-adjuvant chemotherapy in each case.

癌症基因变异

新辅助化疗

Abbreviation: Ade-adenocarcinoma, Squ-squamous carcinoma, AdeSqu-adenosquamous carcinoma; PR-partial response, SD- stable disease; pre-: pre-neoadjuvant chemotherapy, post-: post-neoadjvant chemothera

Figshare2015-12-02 更新40

ER-positive, HER2-low

乳腺癌

新辅助化疗

This data includes 411 ER-positive, HER2-low patients after neoadjuvant chemotherapy.

DataCite Commons2024-03-17 更新60

Patient characteristics in the NAC only group and NAC+ADJ groups, after PS matching.

新辅助化疗

倾向评分匹配

Patient characteristics in the NAC only group and NAC+ADJ groups, after PS matching.

NIAID Data Ecosystem50